📰 Zai Lab News
Page 55 - Zai Lab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Zai Lab. Real-time updates on events, politics, business and more.
June 1, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
June 1, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
May 30, 2022
Developer and publisher 4 I Lab revealed that they will be making the sequel Drunk Or Dead 2 for VR platforms to come out next year.
May 26, 2022
Multispecific Antibodies Cumulative Sales Have Already Surpassed USD 9 Billion By 2021 Says Kuick Research In Recent Reports On Bispecific & Trispecific Antibodies.
May 25, 2022
Frazier Life Sciences announced the addition of Tao Fu as a Venture Partner. He has over 25 years of business development, general management, operations, strategy, and commercial leadership experience
May 24, 2022
24.05.2022 - SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., May 24, 2022 (GLOBE NEWSWIRE) - Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that management from ...
May 22, 2022
Qatar University (QU) has partnered with Huawei to open an AI Lab on campus as part of the Huawei ICT Academy, the technology major announced on Sunday in a
May 22, 2022
INmune Bio (NASDAQ:INMB – Get Rating) and argenx (NASDAQ:ARGX – Get Rating) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Volatility and Risk INmune Bio has a beta of 2.44, suggesting […]
May 22, 2022
Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) and Kintara Therapeutics (NASDAQ:KTRA – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership. Profitability This table compares Paratek Pharmaceuticals and Kintara Therapeutics’ […]
May 20, 2022
Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors because of government incentives, says Dr Mike Tubbs.